\(
\def\WIPO{World Intellectual Property Organisation}
\)
شكل
| تنسيق | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
تفاصيل
Title
Not all pharma IP law is transferable.
نوع المادة
Journal article
الوصف
GB 139 May 2010, p. 96; [28] cm
الرقم الدولي المعياري المسلسل
2044-7175
Alternate Call Number
GB 139
ملخص
The battle for supremacy between Europe and the US in the fields of pharmaceutical R&D and innovation has pointlessly flared up once again. A recently published survey by international intellectual property specialists Marks & Clerk indicates that the US IP system is viewed as being more favourable to innovation and that President Obama's recently passed healthcare reforms are proving to be increasingly palatable for big pharma.
السلسلة
Published
London, England: Informa, U.K. 2010.
اللغة(لغات)
eng
السجل يظهر فى